BioXcel Therapeutics Announces Closing of Initial Public Offering
Mar 12, 2018 20:01 pm UTC| Business
BRANFORD, Conn., March 12, 2018 -- BioXcel Therapeutics, Inc. (“BTI”) (Nasdaq:BTAI), a clinical stage biopharmaceutical development company utilizing novel artificial intelligence to identify the next wave of medicines...
Mistras Group Announces Fourth Quarter 2017 Results
Mar 12, 2018 20:01 pm UTC| Business
Highlights of the Fourth Quarter 2017* Consolidated Q4 revenues increased 10%; Services segment revenues increased 17%Q4 pretax income of $5.0 million increased 140%Q4 net income was $0.9 million; non-GAAP net income...
Vyome Biosciences to Present at The Cowen and Company 38th Annual Health Care Conference
Mar 12, 2018 20:01 pm UTC| Business
NEW DELHI, India, March 12, 2018 -- Vyome Biosciences, a clinical-stage specialty pharmaceutical company developing novel medicines for treating skin diseases caused by resistant microbes, today announces that N....
Mar 12, 2018 20:01 pm UTC| Business
SAN CARLOS, Calif., March 12, 2018 -- Iovance Biotherapeutics, Inc. (NASDAQ:IOVA), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) technology, today reported...
NetApp and Susquehanna Financial Group to Host a Conference Call and Webcast
Mar 12, 2018 20:01 pm UTC| Business
SUNNYVALE, Calif., March 12, 2018 -- NetApp (NASDAQ:NTAP) and Susquehanna Financial Group will hold a conference call to discuss NetApp’s cloud strategy with Brendon Howe, senior vice president, cloud volumes. Following...
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
Mar 12, 2018 20:01 pm UTC| Business
-- Continuing Enrollment in Pivotal Phase 3 Clinical Trial of Setmelanotide in Pro-Opiomelanocortin (POMC) Deficiency Obesity; On Track to Complete Enrollment of 10 Patients in First Half of 2018 ---- Enrolled First...
ICTV Brands, Inc. Announces Definitive Agreement to Sell ClearTouch® for $2.25 million
Mar 12, 2018 20:00 pm UTC| Business
Therma Bright Inc. agreed to acquire certain assets relating to the ClearTouch® nail and skin phototherapy devicesSale price of $2.25 millionICTV enters into a service agreement with Therma Bright to continue to market and...